Denali Therapeutics Inc.

NASDAQ:DNLI

Biotechnology

Healthcare
$18.20 +0.40%

+$0.09 today

Market cap
$2.92B
Beta
1.01
P/E (TTM)
-8.7
EPS (TTM)
-$2.72
52W Low $12.58High $24.65

Volume 1.27M

Average 1.84M

Balance Sheet

Inspect the capital base behind the business.

Assets

$1.14B

FY 2025 · Annual

-16.7% YoY

Liabilities

$131.09M

FY 2025 · Annual

-9.3% YoY

Equity

$1.01B

FY 2025 · Annual

-17.6% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents293.48M218.04M127.11M174.96M205.33M
Short-term Investments571.93M1.12B907.41M657.37M662.55M
Net Receivables1.23M9.28M3.42M2.17M2.18M
Inventory00000
Other Current Assets000030.6M
Total Current Assets897.23M1.37B1.06B864.44M900.66M
Property, Plant & Equipment (Net)69.61M74.52M71.64M125.63M119.94M
Goodwill00000
Intangible Assets00000
Long-term Investments425.45M1.5M0359.37M98.32M
Tax Assets00000
Other Non-current Assets11.87M11.9M18.14M24.74M25.94M
Total Non-current Assets506.93M87.92M89.78M509.74M244.2M
Total Assets1.4B1.46B1.15B1.37B1.14B
Account Payables4.78M2.79M9.48M11.14M3.33M
Short-term Debt00000
Tax Payables00000
Deferred Revenue320.3M290.05M000
Other Current Liabilities19.01M17.09M21.59M38.86M53.28M
Total Current Liabilities378.25M363.92M77.98M102.21M98.35M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)4.69M479K000
Other Non-current Liabilities379K379K05.62M5.53M
Total Non-current Liabilities63.63M53.89M44.98M42.29M32.74M
Total Liabilities441.87M417.81M122.96M144.5M131.09M
Common Stock1.55M1.69M1.71M1.77M1.89M
Retained Earnings(645M)(970.99M)(1.12B)(1.54B)(2.05B)
Accumulated OCI(2.5M)(6.89M)643K2.02M682K
Other Stockholders Equity00000
Minority Interest00000
Total Equity962.29M1.04B1.03B1.23B1.01B
Total Debt64.01M60.35M52.24M48.71M36.76M
Net Debt(229.47M)(157.69M)(74.87M)(126.25M)(168.57M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$201.5M
Short-term Investments$508.9M
Receivables$3.9M
Inventory$4.1M
Other Current$35.4M
Total Current Assets$753.9M
PP&E (Net)$113.4M
Intangible Assets$35.3M
Long-term Investments$229.5M
Other Non-current$25.8M
Total Non-current Assets$404.0M
Total Assets$1.2B

Analysis

Selected assets total $1.2B for Latest. The largest visible component is Short-term Investments at $508.9M, about 44.0% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 3, 2026
10-QQuarterly reportNov 3, 2026
4Statement of changes in beneficial ownershipSep 9, 2026
4Statement of changes in beneficial ownershipSep 4, 2026
4Statement of changes in beneficial ownershipSep 3, 2026

How much cash does DNLI have?

Denali Therapeutics Inc. (DNLI) reported $205.33M in cash and equivalents in fiscal 2025.

How much debt does DNLI carry?

Denali Therapeutics Inc. (DNLI) reported $36.76M of total debt, with net debt of -$168.57M.